Matthew S Deaver

Title: The Innovations of Matthew S. Deaver

Introduction

Matthew S. Deaver is an accomplished inventor based in Lawrence, Kansas. He has made significant contributions to the field of pharmaceuticals, particularly in the development of solid dosage forms. His work has led to advancements that benefit both the industry and patients.

Latest Patents

Matthew S. Deaver holds a patent for solid dosage forms of (S)-ethyl 2-amino-3-(4-(2-amino-6-((R)-1-(4-chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethoxy)pyrimidin-4-yl)phenyl)propanoate. This patent discloses methods of making these pharmaceutical dosage forms, as well as compositions useful in their manufacture. His innovative approach has the potential to enhance the efficacy of treatments.

Career Highlights

Throughout his career, Matthew has worked with notable companies such as Tersera Therapeutics LLC and Lexicon Pharmaceuticals, Inc. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking projects in the pharmaceutical sector.

Collaborations

Matthew has collaborated with esteemed colleagues, including Jinling Chen and Richard J. Holl. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Matthew S. Deaver's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to influence the industry and improve patient outcomes.